These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9251584)
61. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction. Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511 [TBL] [Abstract][Full Text] [Related]
62. Diltiazem comes in from the cold. Purcell H; Fox K Eur Heart J; 2001 Feb; 22(3):185-7. PubMed ID: 11161925 [No Abstract] [Full Text] [Related]
63. Early stopping of trials. Langer A Lancet; 1997 Sep; 350(9081):890-1. PubMed ID: 9310634 [No Abstract] [Full Text] [Related]
64. Diltiazem after thrombolysis. Drummond GA Lancet; 2000 Nov; 356(9241):1604-5. PubMed ID: 11075793 [No Abstract] [Full Text] [Related]
65. Re: Prospective reinfaction outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT). Goodman S; Langer A Can J Cardiol; 1997 Jul; 13(7):693, 696. PubMed ID: 9251584 [No Abstract] [Full Text] [Related]
66. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
67. Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost? Cheiman DM; Shea BF; Kelly RA Pharmacotherapy; 1996; 16(5):861-8. PubMed ID: 8888080 [TBL] [Abstract][Full Text] [Related]
68. Calcium channel blockers: an evidence-based review. Waters D Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842 [TBL] [Abstract][Full Text] [Related]
69. Preventing recurrent myocardial infarction. Use of calcium-channel blockers. Roberts R Postgrad Med; 1988 Jan; 83(1):249-56. PubMed ID: 3275938 [TBL] [Abstract][Full Text] [Related]
70. Calcium antagonists in the therapy of acute myocardial infarction. Stazi F; Verde M; Stazi C; Di Gennaro M Minerva Cardioangiol; 2000; 48(1-2):29-38. PubMed ID: 10829585 [TBL] [Abstract][Full Text] [Related]
71. Safety of heart rate-lowering calcium antagonists: lessons from controlled trials. Messerli FH; Michalewicz L Am Heart J; 1997 Aug; 134(2 Pt 2):S21-4. PubMed ID: 9313620 [No Abstract] [Full Text] [Related]
72. Calcium-channel antagonists in cardiovascular disease. Holdright DR Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671 [TBL] [Abstract][Full Text] [Related]
73. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Cucherat M Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830 [TBL] [Abstract][Full Text] [Related]